- Premature aging in childhood cancer survivors (Review)2023 | Second Faculty of Medicine
- Educational pathways of childhood cancer survivors-a parental cohort2023 | Second Faculty of Medicine
- Subsequent neoplasms in childhood cancer survivors2020 | Second Faculty of Medicine
- Possible mechanisms of subsequent neoplasia development in childhood cancer survivors: A review2021 | Second Faculty of Medicine
- Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: Results from the pancareLIFE study2021 | Second Faculty of Medicine
- Is There a Higher Incidence of Sporadic Renal Angiomyolipoma in Childhood Cancer Survivors?2021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- The Use of Assisted Reproductive Technology by European Childhood Cancer Survivors2022 | Second Faculty of Medicine
- Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE2021 | Second Faculty of Medicine
- Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study2024 | Second Faculty of Medicine
- Health of children born to childhood cancer survivors: Participant characteristics and methods of the Multicenter Offspring Study2021 | Second Faculty of Medicine
- Parenthood for childhood cancer survivors: unfounded fear of cancer development in offspring and related health behaviors2024 | Second Faculty of Medicine
- GH Therapy in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis2019 | First Faculty of Medicine
- Semen analysis and treatment risk factors in long-term survivors of childhood cancer2021 | Second Faculty of Medicine, Central Library of Charles University
- Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol2018 | Second Faculty of Medicine
- PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents2018 | Second Faculty of Medicine
- Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study2019 | Second Faculty of Medicine
- Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters2016 | Second Faculty of Medicine
- Musculoskeletal System Dysfunction in Patients in Long-Term Remission of Wilms NephroblastomaPublication without faculty affiliation
- Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence2020 | Third Faculty of Medicine
- Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study2020 | Second Faculty of Medicine
- Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function2021 | Second Faculty of Medicine